Loading lessons…
Loading lessons…
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
Choose a learning path below or search the library. Progress saves in your browser.
Pick a track — progress rings update as you complete lessons.
4 lessons
7mWeekly amylin agonists are not MOTS-c. Here's when to inject eloralintide for tolerability — dose-day meals, evening vs morning, and what to log.
8mSearching for eloralintide dosage? Here is the clean map of Phase 2 once-weekly doses, titration arms, and weight-loss results — framed as clinical education, not a DIY protocol.
7mAmylin agonists can feel GLP-1-like in the gut. Here's how to think about eloralintide tolerability, escalation, and symptom tracking without turning trial data into fear content.
8mThe MOTS-C dosing debate is real: 0.5-1mg daily vs 5mg 2-3x weekly. Both protocols have their advocates. Here's what the research says, why context matters, and how to choose the right approach for your situation.
Also available at /blog for legacy links.